Resveratrol supplementation reduces the presence of Aβ and tau pathology in the hippocampi of 3×Tg-AD mice, while elevating protein ubiquitination, increasing the levels of proteasome 20S core subunits and enhancing trypsin-like proteasomal activity [154]. The gene discussed is MAPT; the disease is Alzheimer disease.